Loading chat...

ME LD538

Bill

Official Source

Status

Passed

5/27/2025

Primary Sponsor

Sally Cluchey

Click for details

Origin

House of Representatives

132nd Legislature

AI Summary

  • Amends Maine's prescription drug labeling law (32 MRSA §13794) to create an exception for medication abortion drugs
  • Allows prescribers of mifepristone, misoprostol, and their generic alternatives to request their name be omitted from the prescription label
  • Permits the health care facility name to appear on the label instead of the individual practitioner's name when requested
  • Applies only at the prescriber's request; standard labeling requirements remain in effect for all other prescription drugs
  • Signed into law by the Governor on May 29, 2025, as Public Law Chapter 142

Legislative Description

An Act to Amend Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives

Regulation

Last Action

PASSED TO BE ENACTED, in concurrence.

5/27/2025

Committee Referrals

Health Coverage, Insurance and Financial Services2/11/2025

Full Bill Text

No bill text available